|
ADC type
|
Variable
|
Comparison
|
Hazard ratio (95% CI)
|
P value
|
|---|
|
All stages ADC patients (n = 275)
|
Age
|
20–84 years
|
1.057 (1.025–1.090)
|
0.000
|
|
Gender
|
Male; Female
|
1.581 (0.789–3.169)
|
0.196
|
|
Histological grade
|
Grade 1–3
|
1.107 (0.712–1.722)
|
0.652
|
|
Tumor diameter
|
0.8–8 cm
|
0.973 (0.788–1.201)
|
0.796
|
|
Lymph node no
|
0–15
|
1. 014 (0.939–1.096)
|
0.720
|
|
Clinical stage
|
Stage I- IV
|
2.605 (1.852–3.663)
|
0.000
|
|
Tumor location
|
Left; Right
|
0.535 (0.298–0.960)
|
0.036
|
|
SOX30 expression
|
High; Low
|
0.874 (0.807–0.946)
|
0.001
|
|
Stage I ADC patients (n = 112)
|
Age
|
20–84 years
|
1.109 (1.011–1.216)
|
0.028
|
|
Gender
|
Male; Female
|
1.182 (0.155–9.002)
|
0.872
|
|
Histological grade
|
Grade 1; 2; 3
|
4. 702 (0.586–37.737)
|
0.145
|
|
Tumor diameter
|
0.8-7 cm
|
0.954 (0.402–2.268)
|
0.916
|
|
Tumor location
|
Left; Right
|
2. 605 (0.642–10.572)
|
0.180
|
|
SOX30 expression
|
High; Low
|
0.726 (0.567–0.929)
|
0.011
|
- Cox regression analysis was used to test independent prognostic contributions
- CI represents confidence interval. The p < 0.05 was considered statistically significant
- The entries in boldface indicate statistically significant
